Related Experiment Video
Updated: Jun 22, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Early-phase clinical trials of anti-HIV drugs-understanding and discussion
YaJie LI1, Ming ZHAO, DeHeng ZHAO
1Center for Drug Evaluation, State Food and Drug Administration, Beijing 100038, China, liyj@cde.org.cn
Abstract:
Innovative anti-HIV drugs developed by local sponsors in China have come into the stage of early-phase clinical trials. How to systemically design the clinical trials of innovative anti-HIV drugs still remains a challenge for them. This article references the literature and the experience of reviewers, to introduce general considerations concerning early-phase clinical trials of innovative anti-HIV drugs.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Retrovirus Life Cycles
Preclinical Development: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Inhibitors of Virion Maturation and Assembly
